Business Standard

NPPA heat on hospitals for failing to provide stent details

Hospitals not providing these details could be accused of distorting evidence deliberately

NPPA heat on hospitals for failing to provide stent details
Premium

Veena Mani New Delhi
The National Pharmaceutical Pricing Authority (NPPA) has said hospitals not providing details of the brand of stents they are selling patients would be prosecuted under the provisions of the Essential Commodities Act, 1955.

The drug price regulator also said hospitals not providing these details could be accused of distorting evidence deliberately.

On February 13, NPPA fixed the ceiling price of drug-eluting stents at Rs 30,000 and of bare metal ones at Rs 7,500. In 2016, 600,000 stents were used in the country, over 90 per cent of which were drug-eluting and priced between Rs 24,000 and Rs 1.5 lakh then.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in